Literature DB >> 33177308

Prevalence and Prognosis of Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome in Mie Prefecture, Japan - Report From Mie ACS Registry.

Akihiro Takasaki1, Tairo Kurita1, Jun Masuda2, Kozo Hoshino3, Tetsuya Seko4, Takashi Tanigawa5, Tetsuya Kitamura6, Takehiko Ichikawa7, Masaaki Ito1, Kaoru Dohi1.   

Abstract

BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevated low-density lipoprotein cholesterol concentration and premature acute coronary syndrome (ACS). However, hereditary diseases may have regional characteristics, and few data are available regarding the prevalence of FH throughout particular regions in Japan. This study investigated the prevalence and prognosis of FH in patients with ACS in Mie Prefecture, Japan.Methods and 
Results: This study investigated 738 ACS patients from the Mie ACS Registry in Mie Prefecture, and 706 (95.7%) with sufficient data to diagnose FH were enrolled for analysis. Eighteen patients (2.5%) were diagnosed with FH, which was similar to findings of another multidistrict registry conducted in Japan. Patients with FH were significantly younger and had a higher prevalence of premature onset of ACS than patients with non-FH (P<0.01). Incidence of major adverse cardiac and cerebrovascular events (MACCE) was not statistically different between patients with FH and non-FH in this study population, even in the propensity score-matched analysis.
CONCLUSIONS: Prevalence of FH in ACS patients from the Mie Prefecture was similar to that found in another Japanese multidistrict registry. Among ACS patients, short-term incidence of MACCE was not statistically different between patients with FH and non-FH in this study population.

Entities:  

Keywords:  Acute coronary syndrome; Familial hypercholesterolemia; Prognosis

Mesh:

Year:  2020        PMID: 33177308     DOI: 10.1253/circj.CJ-20-0112

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects.

Authors:  Yani Yu; Lei Chen; Honghong Zhang; Zihao Fu; Qi Liu; Haijing Zhao; Yuqi Liu; Yundai Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-21

2.  Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome.

Authors:  Cheng Wang; Puliang Yu; Lizhi Hu; Minglu Liang; Yi Mao; Qiutang Zeng; Xiang Wang; Kai Huang; Jin Yan; Li Xie; Fengxiao Zhang; Feng Zhu
Journal:  Front Cardiovasc Med       Date:  2022-07-27

3.  Demographic Trends and Changes in the Pre- and In-Hospital Medical Management of Acute Myocardial Infarction During the First 12 Months of the COVID-19 Pandemic in Mie Prefecture - Report From the Mie ACS Registry.

Authors:  Akihiro Takasaki; Tairo Kurita; Masashi Yanagisawa; Ayaka Ino; Daisuke Hiramatsu; Akiyoshi Ikami; Hiromasa Ito; Takashi Kato; Shusuke Fukuoka; Tadafumi Sugimoto; Tomoyuki Nakata; Jun Masuda; Masaki Tanabe; Hitoshi Kakimoto; Kaoru Dohi
Journal:  Circ Rep       Date:  2022-08-18

Review 4.  Individualized Treatment for Patients With Familial Hypercholesterolemia.

Authors:  Hayato Tada; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Lipid Atheroscler       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.